Acute hepatitis C virus (HCV) infections in the US have increased more than 3-fold since 2010.1 In 2017, there were an estimated 44 700 cases of acute HCV infection in the US,2 which is more than the 37 377 cases of HIV reported.3 In addition, there are now more deaths annually from HCV infection than from HIV in the US2,3; in 2017, HCV infection accounted for 17 253 deaths2 and HIV accounted for 15 971 deaths.3 Deaths related to HCV infection are considered to be largely preventable because therapies are now readily available that can achieve virological cure (defined as undetectable HCV infection in the blood for ≥12 weeks after completing treatment, and referred to as a sustained virological response).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Havens PL, Anderson JR. Updated CDC Recommendations for Universal Hepatitis C Virus Screening Among Adults and Pregnant Women: Implications for Clinical Practice. JAMA. 2020;323(22):2258–2259. doi:10.1001/jama.2020.3693
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: